Basic fibroblast growth factor (bFGF) requires heparan sulfate (HS) that contains bFGF-binding domains for regulating gllomerular cell apoptosis (AP)
Basic fibroblast growth factor (bFGF) requires heparan sulfate (HS) that contains bFGF-binding domains for regulating gllomerular cell apoptosis (AP)
批准号:
07671247
负责人:
SHINZATO Toru
金额:
$1.28万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Basic FGF can function as a survival factor in certain cell lineages. It requires a cofactor, HS or heparin (HP), for the activation of signal-transducing bFGF receptors. HS/HP are heterogeneous carbohydrates. We hypothesized that specific interaction between bFGF and bFGF-binding domains of HS might optimize bFGF's ability of regulating AP induced in glomerular cells. To test this hypothesis, we compared the effects of various forms of glycosaminoglycans (GAG). Two types of Engelbreth-Holm-Swarm tumor HS with respect to the affinity for bFGF were fractionated : the bound and unbound HS.The bound HS were enriched in IdoA(2SO4)-GlcNSO3 units. In order to trigger AP,a) isolated glomeruli from Wistar rats were incubated with Trimeresurus flavoviridis vebom, or b) rat mesangial cells in culture were deprived growth factors. The bound HS,te unbound HS,or either one of the other forms of GAG (HP,hyaluronate, chondroitin sulfate, dermatan sulfate and keratan sulfate) was added to the culture media at various concentrations (4ng/ml-40mug/ml) with bFGF (0.5-5.0ng/ml) in the presence or absence of cycloheximide (250muM). To detect DNA cleavage and subsequent nuclear changes typical of AP,DNA electrophoresis, light microscopic examination and TdT-mediated dUTP-biotin nick and labeling (TUNEL) were conducted. AP of the isolated glomeruli and cultured mesangial cells were successfully introduced. To rescue AP,5.0ng/ml of bFGF required HS or HS (5.0mug/ml or more as uronate) that contains bFGF-binding portions. Cycloheximide treatment inhibited this activity of bFGF.Other GAG did not give such regulatory effects at the same concentration.Conclusion : The results suggest that the bFGF-binding portions help regulate AP.These studies may contribute toward establishing a framework for the molecular design of carbohydrates capable of optimizing bFGF activity.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Toru Shinzato, et all: "Immunohistochemical localization of β2-microglobulin and advanced glycation end products in amyloid-enriched carpal tunnel ligament" Nephron. 73. 117-118 (1996)
Toru Shinzato 等人:“富含淀粉样蛋白的腕管韧带中 β2-微球蛋白和晚期糖基化终产物的免疫组织化学定位”Nephron 73. 117-118 (1996)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Toru Shinzato, et all: "Immunohistochemical localization of b2-microglobulin and advanced glycation end products in amyloid-enriched carpal tunnel ligament." Nephron. 73. 117-118 (1996)
Toru Shinzato 等人:“b2-微球蛋白和晚期糖基化终产物在富含淀粉样蛋白的腕管韧带中的免疫组织化学定位。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Toru Shinzato, et all: "Basic fibroblast growth factor-heparan sulphate complex in the human dialysis-related amyloidosis" Virchows Arch. 427. 395-400 (1995)
Toru Shinzato 等人:“人类透析相关淀粉样变性中的碱性成纤维细胞生长因子-硫酸乙酰肝素复合物”Virchows Arch。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Toru Shinzato, et all: "Basic fibroblast growth factor-heparan sulphate complex in the human dialysis-related amyloidosis." Virchows Arch. 427. 395-400 (1995)
Toru Shinzato 等人:“人类透析相关淀粉样变性中的碱性成纤维细胞生长因子-硫酸乙酰肝素复合物。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Toru Shinzato,et all: "Basic fibroblast growth factor-heparan sulphate complex in the human dialysis-related amyloidosis" Virchows Arch. 427. 395-400 (1995)
Toru Shinzato 等人:“人类透析相关淀粉样变性中的碱性成纤维细胞生长因子-硫酸乙酰肝素复合物”Virchows Arch。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 10 条
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: